212 related articles for article (PubMed ID: 8803911)
1. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience.
Kahan A; Menkès CJ
Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911
[TBL] [Abstract][Full Text] [Related]
2. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
3. [Combination therapy of rheumatoid arthritis].
Hansen A; Jensen T
Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
[TBL] [Abstract][Full Text] [Related]
4. The BeSt story: on strategy trials in rheumatoid arthritis.
Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
[TBL] [Abstract][Full Text] [Related]
5. [Combination therapy in rheumatoid arthritis].
Johnsen V; Førre Ø; Haga HJ; Kvien TK; Mikkelsen K; Nordvåg BY; Rødevand E
Tidsskr Nor Laegeforen; 2003 May; 123(11):1511-3. PubMed ID: 12822010
[TBL] [Abstract][Full Text] [Related]
6. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
7. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
Pincus T; Sokka T
Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
[No Abstract] [Full Text] [Related]
8. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
[TBL] [Abstract][Full Text] [Related]
9. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
[No Abstract] [Full Text] [Related]
10. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
11. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
12. [Armentarium and strategies for the treatment of rheumatoid arthritis].
Lioté F
Rev Prat; 2005 Dec; 55(19):2146-60. PubMed ID: 16544925
[TBL] [Abstract][Full Text] [Related]
13. Are biologics more effective than classical disease-modifying antirheumatic drugs?
Nurmohamed MT; Dijkmans BA
Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
[TBL] [Abstract][Full Text] [Related]
14. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
[TBL] [Abstract][Full Text] [Related]
15. Is combination second-line therapy in rheumatoid arthritis more aggressive than helpful?
Berthelot JM; Saraux A; Maugars Y; Prost A; Le Goff P
Rev Rhum Engl Ed; 1999 Apr; 66(4):224-8. PubMed ID: 10339779
[No Abstract] [Full Text] [Related]
16. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
Shiroky JB
J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
18. History of combination therapy of rheumatoid arthritis.
Paulus HE
J Rheumatol Suppl; 1996 Mar; 44():38-42. PubMed ID: 8833050
[TBL] [Abstract][Full Text] [Related]
19. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
Simon LS
Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
[TBL] [Abstract][Full Text] [Related]
20. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
